Kaya Holdings (KAYS) Depreciation and Depletion (2011 - 2023)
Kaya Holdings (KAYS) recorded quarterly Depreciation and Depletion of $3297.0 in Q2 2023, down 6.28% quarter-over-quarter from $3518.0 in Q1 2023, and down 40.97% on a YoY basis from $5585.0 in Q2 2022.
Kaya Holdings (KAYS) Depreciation and Depletion (2011 - 2023) Analysis & Trends
Kaya Holdings' Depreciation and Depletion history runs 13 years deep, the most recent figure standing at $3297.0 for Q2 2023.
- In Q2 2023, Depreciation and Depletion fell 40.97% year-over-year to $3297.0; the TTM figure through Jun 2023 stood at $1230.0 (down 98.3% YoY), while the FY2022 annual figure was $8027.0, down 93.26% from the prior year.
- Depreciation and Depletion was $3297.0 for Q2 2023 at Kaya Holdings, down from $3518.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $57910.0 in Q2 2019 to a low of -$24254.0 in Q4 2020.
- Historically, Depreciation and Depletion has averaged $27984.7 across 5 years, with a median of $30121.0 in 2021.
- The sharpest annual moves came in 2020 and 2021: Depreciation and Depletion plunged 143.11% in 2020, then surged 208.53% in 2021.
- A 5-year view of Depreciation and Depletion shows it stood at $56265.0 in 2019, then plunged by 143.11% to -$24254.0 in 2020, then soared by 208.53% to $26324.0 in 2021, then tumbled by 137.26% to -$9809.0 in 2022, then surged by 133.61% to $3297.0 in 2023.
- The last three Depreciation and Depletion figures came in at $3297.0 (Q2 2023), $3518.0 (Q1 2023), and -$9809.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 36.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 21.60 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 7.20 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 28.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Kaya Holdings | - | - | 5,370.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3,297.00 |
| Jun 30, 2023 | 3,297.00 |
| Mar 31, 2023 | 3,518.00 |
| Mar 31, 2023 | 3,518.00 |
| Dec 31, 2022 | -9,809.00 |
| Dec 31, 2022 | -9,809.00 |
| Sep 30, 2022 | 4,224.00 |
| Sep 30, 2022 | 4,224.00 |
| Jun 30, 2022 | 5,585.00 |
| Jun 30, 2022 | 5,585.00 |
| Mar 31, 2022 | 8,027.00 |
| Mar 31, 2022 | 8,027.00 |
| Dec 31, 2021 | 26,324.00 |
| Dec 31, 2021 | 26,324.00 |
| Sep 30, 2021 | 32,473.00 |
| Sep 30, 2021 | 32,473.00 |
| Jun 30, 2021 | 29,980.00 |
| Jun 30, 2021 | 29,980.00 |
| Mar 31, 2021 | 30,262.00 |
| Mar 31, 2021 | 30,262.00 |